AU4147200A - Cancer cell-specific gene expression system - Google Patents

Cancer cell-specific gene expression system

Info

Publication number: AU4147200A
Authority: AU; Australia
Prior art keywords: gene expression; cancer cell; expression system; specific gene; specific
Prior art date: 1999-12-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU41472/00A

Inventor

Jung-Hee Han

Chang Kyu Kim

Kwang Dong Kim

Jong Seok Lim

Mi Jung Lim

Young Il Yeom

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Chong Kun Dang Corp

Korea Research Institute of Bioscience and Biotechnology KRIBB

Original Assignee

Chong Kun Dang Corp

Korea Research Institute of Bioscience and Biotechnology KRIBB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-31

Filing date

2000-04-10

Publication date

2001-07-16

2000-04-10 Application filed by Chong Kun Dang Corp, Korea Research Institute of Bioscience and Biotechnology KRIBB filed Critical Chong Kun Dang Corp

2001-07-16 Publication of AU4147200A publication Critical patent/AU4147200A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU41472/00A 1999-12-31 2000-04-10 Cancer cell-specific gene expression system Abandoned AU4147200A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
KR9968205		1999-12-31
KR19990068205		1999-12-31
PCT/KR2000/000330 WO2001049868A1 (en)	1999-12-31	2000-04-10	Cancer cell-specific gene expression system

Publications (1)

Publication Number	Publication Date
AU4147200A true AU4147200A (en)	2001-07-16

Family

ID=19635291

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU41472/00A Abandoned AU4147200A (en)	1999-12-31	2000-04-10	Cancer cell-specific gene expression system

Country Status (2)

Country	Link
AU (1)	AU4147200A (en)
WO (1)	WO2001049868A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2304281B1 (en) *	2006-02-01	2009-08-12	Dnatrix Inc.	ADENOVIRUS ONCOLITICOS FOR THE TREATMENT OF CANCER.
WO2007127165A2 (en) *	2006-04-27	2007-11-08	The Trustees Of Columbia University In The City Of New York	A gene therapy construct that induces selective apoptosis in cells with mutant ras and mutant p53, and methods of use for treating cancer
EP3229022A1 (en) *	2016-04-07	2017-10-11	Universitat Pompeu-Fabra	Identification of candidate anticancer drugs based on retinoblastoma phosphorylation at ser249/thr252
EP3847261A1 (en) *	2018-09-05	2021-07-14	Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft	A method for engineering synthetic cis-regulatory dna

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9506466D0 (en) *	1994-08-26	1995-05-17	Prolifix Ltd	Cell cycle regulated repressor and dna element
DE19605274A1 (en) *	1996-02-13	1997-08-14	Hoechst Ag	Nucleic acid constructs for the cell cycle regulated expression of genes, cells containing such constructs and their use for the production of medicinal products

2000
- 2000-04-10 AU AU41472/00A patent/AU4147200A/en not_active Abandoned
- 2000-04-10 WO PCT/KR2000/000330 patent/WO2001049868A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2001049868A1 (en)	2001-07-12

Publication	Publication Date	Title
AU3369900A (en)	2000-09-04	Gene silencing
AU6181300A (en)	2001-02-19	Liver cancer-associated genes
AU6731800A (en)	2001-03-26	Data distribution system
AU6005600A (en)	2001-02-13	Data distribution
AU7837800A (en)	2001-04-30	Rapid infusion system
AU5090200A (en)	2001-12-11	Culture chamber
AU1922301A (en)	2001-05-30	Differential gene expression in cancer
AU4286199A (en)	2000-12-18	Computer system
AU3565600A (en)	2000-11-14	Computer system
AU3528400A (en)	2000-10-09	Apoptosis related genes
AUPQ262599A0 (en)	1999-09-23	Gene expression
AU3178200A (en)	2000-10-04	Genetic analysis
AU8026300A (en)	2001-04-23	Sodd gene expression in cancer
AU2376200A (en)	2000-07-24	Insulin-synthesis genes
AU7606100A (en)	2001-04-24	Gene expression profiles
AU4147200A (en)	2001-07-16	Cancer cell-specific gene expression system
AU7567101A (en)	2001-11-26	Gene expression system
AU6859500A (en)	2001-04-10	Plant gene
AU6001200A (en)	2001-02-19	Expression system
AU7064500A (en)	2001-03-19	Human narcolepsy gene
AU3987100A (en)	2000-11-10	Computer system
AU1870000A (en)	2000-07-24	Gene therapy-2
AU6871900A (en)	2001-04-10	Tsg-like gene
AU6017900A (en)	2001-05-14	Novel tumor suppressor gene
AU6648100A (en)	2001-05-08	Human narcolepsy gene

Legal Events

Date	Code	Title	Description
2002-08-29	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase